TelyRx Holdings Inc. (TSX:TELY)
Canada flag Canada · Delayed Price · Currency is CAD
2.600
0.00 (0.00%)
At close: Aug 14, 2026

TelyRx Holdings Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
68.7242.929.530.03
Revenue Growth
-350.27%35207.41%-
Cost of Revenue
30.2519.616.020.03
Gross Profit
38.4623.323.510
Selling, General & Admin
49.5127.37.160.72
Operating Expenses
50.5528.087.440.75
Operating Income
-12.09-4.76-3.93-0.75
Interest Expense
-0.67-0.66-0.93-0.89
Other Non Operating Income (Expenses)
0.020.02--
EBT Excluding Unusual Items
-12.74-5.41-4.86-1.64
Other Unusual Items
-0.54-0.03-
Pretax Income
-13.28-5.41-4.83-1.64
Income Tax Expense
0.020.02--
Earnings From Continuing Operations
-13.3-5.43-4.83-1.64
Earnings From Discontinued Operations
---8.65-2.76
Net Income
-13.3-5.43-13.48-4.39
Net Income to Common
-13.3-5.43-13.48-4.39
Net Income Growth
----
Shares Outstanding (Basic)
20118-
Shares Outstanding (Diluted)
20118-
Shares Change
-40.47%--
EPS (Basic)
-0.65-0.51-1.77-
EPS (Diluted)
-0.65-0.51-1.77-
EPS Growth
----
Free Cash Flow
-6.76-1.36-3.07-2.51
Free Cash Flow Per Share
-0.33-0.13-0.40-
Gross Margin
55.97%54.32%36.84%7.41%
Operating Margin
-17.59%-11.10%-41.19%-2762.96%
Profit Margin
-19.36%-12.64%-141.44%-16274.07%
Free Cash Flow Margin
-9.83%-3.16%-32.17%-9277.78%
EBITDA
-12.21-4.67-3.92-0.71
EBITDA Margin
-17.77%-10.87%-41.10%-
D&A For EBITDA
-0.130.10.010.03
EBIT
-12.09-4.76-3.93-0.75
EBIT Margin
-17.59%-11.10%-41.19%-